Press releases, Reports & Disclosures for National International Holding Company
Disclosure: Notification from the company
National International Holding Company (NIH) has received approval from the Capital Markets Authority (CMA) to buy or sell up to 10% of its treasury shares. This approval is valid for six months starting from August 27, 2024, and is subject to the availability of financial resources, in accordance with Law no. 7 of 2010 and its subsequent amendments. The company states that this action will have no impact on its financial position. The letter was signed by Mamdouh A. EL Sherbiny, CEO and Board Member of NIH.
Disclosure: Results of BOD meeting including F.S of Q2-2024
Disclosure: Results of BOD Meeting
Disclosure: Financial statements for the 2n QTR of 2024
Disclosure: BOD meeting
Disclosure: Clarification from the company
Disclosure: Announcement from the company
Disclosure: Supplementary Disclosure - AGM Minutes of meeting
Disclosure: Entitlement Dates
Disclosure: Resolutions of General Assembly